Sign In
Buy PFE
$25.36
-0.200 (-0.783%)
At Close: Jun 03, 2026
Perigon Wealth Management LLC Has $3.83 Million Stake in Pfizer Inc. $PFE
06:13am, Monday, 29'th Dec 2025
Perigon Wealth Management LLC raised its position in Pfizer Inc. (NYSE: PFE) by 22.6% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Excha
Pfizer Inc. $PFE Shares Sold by Burney Co.
04:16am, Monday, 29'th Dec 2025
Burney Co. lowered its position in Pfizer Inc. (NYSE: PFE) by 33.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC).
The Smartest Dividend Stocks to Buy With $3,000 Right Now
09:15pm, Sunday, 28'th Dec 2025
These businesses have both steadily increased their payouts. Lowe's is focusing on the lucrative professional contractor market.
3 Drug Stocks to Buy at a Discount
04:28pm, Saturday, 27'th Dec 2025
Eli Lilly is currently leading the market for GLP-1 drugs, taking the pole position from Novo Nordisk. Novo Nordisk just got approval for a GLP-1 pill, which could again upend the dynamics for weight
3 Superb High-Yield Dividend Stocks With Yields North of 5% That Make for No-Brainer Buys Right Now
06:30am, Saturday, 27'th Dec 2025
Realty Income has a robust dividend yield and a rock-solid, diversified business. Pfizer has a high cash balance, is rolling out new products, and is well-poised to grow its business while supporting
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Friday, 26'th Dec 2025
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Lilly and Novo Cut GLP-1 Prices as Pill Approvals Expand Access
08:01am, Friday, 26'th Dec 2025
Weight-loss drugs known as GLP-1s are increasingly reshaping healthcare and the pharmaceutical landscape, with Eli Lilly (LLY) and Novo Nordisk (NVO) emerging a
DAVENPORT & Co LLC Boosts Stake in Pfizer Inc. $PFE
04:16am, Thursday, 25'th Dec 2025
DAVENPORT and Co LLC lifted its holdings in shares of Pfizer Inc. (NYSE: PFE) by 8.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned
PFE's Oncology & Obesity Pipeline Position It for Post-LOE Growth
12:21pm, Wednesday, 24'th Dec 2025
Pfizer faces revenue pressure from 2026-2030 LOEs but is betting on a strengthened oncology and obesity pipeline to fuel sustainable post-LOE growth.
3 Under-The-Radar Dividend Stocks to Buy on the Cheap
07:48am, Wednesday, 24'th Dec 2025
Dividend stocks have been under pressure in the past few years due to the broader economy's unpredictable swings.
Pfizer (PFE) Stock Slides as Market Rises: Facts to Know Before You Trade
06:46pm, Tuesday, 23'rd Dec 2025
In the latest trading session, Pfizer (PFE) closed at $24.88, marking a -1.31% move from the previous day.
Novo Nordisk's Wegovy Pill Gains FDA Approval, Boosting Weight Loss Market Prospects
01:14pm, Tuesday, 23'rd Dec 2025
Novo Nordisk (NVO) saw a significant stock surge following the FDA's approval of the Wegovy pill for weight loss. This makes it the first oral GLP-1 receptor ag
Pfizer says patient dies after receiving hemophilia drug in trial
11:24am, Tuesday, 23'rd Dec 2025
A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing serious side effects, the company said.
Pfizer Stock Is Down -- Patient Death in Hemophilia Study Raises Safety Concerns
11:15am, Tuesday, 23'rd Dec 2025
Pfizer (PFE) shares slid about 1% Tuesday morning after reports that a patient died while receiving the company's hemophilia drug Hympavzi, highlighting challen
Novo Nordisk Shares Surge 7% In Tuesday Pre-Market After US FDA Approves Wegovy Pill
04:30am, Tuesday, 23'rd Dec 2025
U.S.-listed shares of Novo Nordisk A/S soared 7.36% during Tuesday's pre-market session following the approval of its GLP-1 pill by the U.S. FDA.
